Gerald G. Krueger

Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways

Rajan P. Nair, Kristina Callis Duffin, Cynthia Helms et al. · Nature Genetics · 2009 · 1.4K citations · Full text

Inflammation, Cytokine, Immune Cell Development +7

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Kim Papp, Richard G. Langley, Mark Lebwohl et al. · The Lancet · 2008 · 1.3K citations

Immunology, Clinical Trials, Clinical Dermatology +7

A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes

Michele Cargill, Steven J. Schrodi, Monica Chang et al. · The American Journal of Human Genetics · 2007 · 1.1K citations · Full text

Inflammation, Immunogenetics, Medicine +9

A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis

Gerald G. Krueger, Richard G. Langley, Craig L. Leonardi et al. · New England Journal of Medicine · 2007 · 780 citations · Full text

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Christian Antoni, Gerald G. Krueger, Kurt de Vlam et al. · Annals of the Rheumatic Diseases · 2005 · 704 citations · Full text